Immune-Targeted Therapy with or without Transarterial Chemoembolization (TACE) for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis (PVTT): A Multicenter Retrospective Study
TACE combined with IT provides a safe and effective treatment option for advanced-HCC patients with PVTT, particularly those with abundant PVTT blood supply.
Authors
- Yuan Cheng (ORCID: https://orcid.org/0009-0003-0378-6221)
- Bin Leng (ORCID: https://orcid.org/0009-0007-5370-342X)
- Qingyu Xu (ORCID: https://orcid.org/0000-0003-2281-4454)
- Chendong Wang (ORCID: https://orcid.org/0000-0002-8334-0232)
- Ran You (ORCID: https://orcid.org/0000-0003-3852-5569)
- Lingfeng Diao
- Guowen Yin
- Zeyu Yu (ORCID: https://orcid.org/0009-0003-1100-7953)
Institutions
- Nanjing University of Chinese Medicine (CN)
- 81th Hospital of PLA (CN)
- Jiangsu Cancer Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Biomedicines
- Published
- 2024-09-19
- DOI
- https://doi.org/10.3390/biomedicines12092124
- Citations
- 3
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.11